EHR
Electronic health records — risk management and best practices
-
Read ArticleA group admin explains what business interruption really means
What happens when a system failure brings down the EMR?
-
Read ArticleGuidelines for the release of medical records
It is imperative to have a system in place that allows the release of complete, legible, and organized records from your medical office.
-
View PresentationEHR best practices
TMLT is focused on helping physicians reduce their liability risks as they navigate the world of electronic documentation. Please consider the following to help reduce risk related to EHR systems.
-
Need a risk assessment? Our experts can help.
Contact Us -
Read Article
6 tips to improve patient communication while using your EHR
View part three of a three part video series on improving physician/patient interactions.
-
Read FlipbookThe Reporter Volume 5 2015
TMLT's 2015 Texas legislative successes; Gaining the best value from your EHR (2.5-hour CME)
-
Read FlipbookThe Reporter Volume 2 2015
EHR best practices: complying with new TMB documentation rules: Advanced Practice Providers: Rules, Regulations, and Physician Supervision (CME activity); New telemedicine rules.
-
Read FlipbookThe Reporter November-December 2010
Electronic medical records and emerging changes to HIPAA; There is an "e" in medicine (CME); FDA restricts access to diabetes drug rosiglitazone (Avandia)
-
Read FlipbookReporter 2009 Pediatrics
Failure to diagnose meningitis; PIAA releases national pediatric closed claim data; EMR product evaluation tool now available from TMA
-
Read Article
Potential pitfalls: Risk management for the EMR
Documentation pitfalls specifically related to electronic medical records (EMRs) and how to avoid them.
-
Read FlipbookThe Reporter July-August 2005
Drug name confusion; Electronic health records (exp. CME); Failure to communicate diagnosis of abdominal cancer; 2005 legislative update
-
Read FlipbookThe Reporter May-June 2002
The move to electronic medicine; Medical liability update; Failure/delay in diagnosis: Cancer; Botox parties, FDA prescription drug notices, changes in generic drug substitution laws
-
Loading More...
